CA
NZ
UK
AU
IND
US
…
TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -28.74M | -12.77M | -6.04M | -5.57M | -12.61M |
| Net income | -28.74M | -12.77M | -6.04M | -5.57M | -12.61M |
| Selling general administrative | 9.02M | 5.21M | 6.34M | 9.81M | 8.28M |
| Gross profit | 0.30M | - | - | - | - |
| Reconciled depreciation | 0.00M | 0.01M | 0.01M | 0.01M | 0.00M |
| Ebit | -9.05M | -6.81M | -8.31M | -16.13M | -12.62M |
| Ebitda | -9.04M | -6.81M | -8.31M | -16.13M | -12.61M |
| Depreciation and amortization | 0.00M | 0.01M | 0.01M | 0.01M | 0.00M |
| Operating income | -9.05M | -6.81M | -8.31M | -16.13M | -12.62M |
| Other operating expenses | 9.35M | 6.81M | 8.31M | 16.13M | 12.62M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.44M | 1.28M | 1.65M | 0.34M | 0.01M |
| Net interest income | 0.44M | 1.28M | 1.65M | 0.34M | 0.01M |
| Total revenue | 0.30M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 9.35M | 6.81M | 8.31M | 16.13M | 12.62M |
| Total other income expense net | -19.69M | -5.96M | 2.28M | 10.56M | 0.01M |
| Net income from continuing ops | -28.74M | -12.77M | -6.04M | -5.57M | -12.61M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 25.84M | 17.73M | 31.11M | 38.61M | 35.52M |
| Other current assets | 19.88M | 0.06M | 0.43M | 1.11M | 1.29M |
| Total liab | 3.94M | 10.96M | 5.53M | 3.19M | 1.99M |
| Total stockholder equity | 21.90M | 6.78M | 25.58M | 35.41M | 33.53M |
| Other current liab | 0.64M | 0.70M | 3.83M | 0.65M | 0.70M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.85M | 0.91M | 1.24M | 2.72M | 0.00M |
| Retained earnings | -76.20M | -47.17M | -33.61M | -19.83M | -14.14M |
| Cash | 5.50M | 17.66M | 28.66M | 37.48M | 34.21M |
| Total current liabilities | 1.81M | 1.01M | 4.28M | 1.31M | 1.99M |
| Net debt | -5.50M | -17.66M | -28.66M | -37.48M | -34.21M |
| Other stockholder equity | 97.24M | 53.03M | 57.96M | 52.52M | 47.67M |
| Total current assets | 25.38M | 17.72M | 30.53M | 38.59M | 35.50M |
| Long term investments | 0.45M | 0.00M | 0.56M | 0.00M | - |
| Short term investments | - | 0.00M | 1.44M | 0.00M | - |
| Accounts payable | 1.18M | 0.32M | 0.44M | 0.66M | 1.30M |
| Accumulated other comprehensive income | 0.01M | 0.01M | 0.00M | - | - |
| Non current assets total | 0.46M | 0.01M | 0.58M | 0.02M | 0.02M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -28.14M | -1.00M | -2.00M | -0.01M | -0.00M |
| Total cashflows from investing activities | -28.89M | -1.00M | -2.00M | -0.01M | -0.00M |
| Total cash from financing activities | 23.13M | -5.12M | -1.64M | 14.48M | 37.13M |
| Net income | -28.74M | -12.77M | -6.04M | -5.57M | -12.61M |
| Change in cash | -12.16M | -11.01M | -8.82M | 3.26M | 28.42M |
| Begin period cash flow | 17.66M | 28.66M | 37.48M | 34.21M | 5.80M |
| End period cash flow | 5.50M | 17.66M | 28.66M | 37.48M | 34.21M |
| Total cash from operating activities | -6.40M | -4.88M | -5.17M | -11.21M | -8.71M |
| Issuance of capital stock | 14.86M | 4.46M | 0.00M | 13.93M | 23.78M |
| Depreciation | 0.00M | 0.01M | 0.01M | 0.01M | 0.00M |
| Dividends paid | 0.26M | 0.95M | 0.64M | 0.00M | 0.00M |
| Sale purchase of stock | -1.43M | -8.63M | -1.00M | 0.00M | - |
| Other cashflows from financing activities | 14.86M | -4.17M | -1.00M | 0.55M | 13.35M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M |
| Change in working capital | 0.42M | 0.50M | 0.36M | -0.61M | 0.03M |
| Stock based compensation | 1.39M | 0.03M | 1.01M | 3.74M | 3.28M |
| Other non cash items | 20.53M | 7.35M | -0.51M | -8.77M | 0.59M |
| Free cash flow | -6.40M | -4.88M | -5.18M | -11.22M | -8.71M |
Sector: Financial Services Industry: Capital Markets
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TAOX TAO Synergies Inc. |
-0.03 1.16% |
2.55 | 2.36 | - | 35.50 | 2.29 | 40.60 | 1.28 |
| GS Goldman Sachs Group Inc |
16.62 1.83% |
926.81 | 17.21 | 16.00 | 4.47 | 2.26 | 11.15 | - |
| SCHW Charles Schwab Corp |
-0.25 0.27% |
92.78 | 19.53 | 13.89 | 7.16 | 4.22 | 8.80 | - |
| MS Morgan Stanley |
2.95 1.57% |
190.51 | 16.50 | 13.76 | 2.80 | 1.65 | - | - |
| IBKR Interactive Brokers Group Inc |
4.90 6.32% |
82.49 | 35.95 | 27.93 | 22.14 | 6.96 | 3.01 | 3.37 |
TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.
1185 Avenue of the Americas, New York, NY, United States, 10036
973 242 0005
4
| Name | Title | Year Born |
|---|---|---|
| Mr. Joshua N. Silverman | Executive Chairman of the Board | 1970 |
| Mr. Robert Weinstein | CFO, Executive VP, Treasurer & Secretary | 1960 |
| Dr. Alan J. Tuchman M.D., MBA(FAAN) | Chief Medical Officer | 1947 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.29%
Communication Services
+0.51%
Consumer Cyclical
-0.08%
Consumer Defensive
-0.14%
Energy
+1.08%
Financial Services
+0.14%
Financials
-0.06%
Healthcare
+0.51%
Industrials
+0.47%
Real Estate
-0.23%
Technology
+2.03%
Utilities
-0.13%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...